Biosortia Pharmaceuticals
Business Services · Ohio, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4266 Tuller Rd, Dublin, Ohio, 43017, Uni...Phone Number
(614) 573-1903Website
www.biosortia.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Biosortia Pharmaceuticals
Biosortia Microbiomics specializes in industrial scale microbiome mining, providing a new toolbox for drug discovery by leveraging untapped microbial resources. The company offers a library of novel small molecules derived from natural microbiomes, which are biologically optimized for life science applications. Additionally, Biosortia licenses its exclusive database to assist organizations in utilizing machine learning and artificial intelligence for various research and development needs. Their services cater to a wide range of clients, including those in therapeutics, agrochemicals, sustainability, and academic research collaborations.Explore more
Biosortia Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biosortia Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Biosortia Pharmaceuticals recently announced quarterly report
Biosortia Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Biosortia Pharmaceuticals has new funding data
Check if Biosortia Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Biosortia Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Biosortia Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Biosortia Pharmaceuticals
Click to see if Biosortia Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Biosortia Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Biosortia Pharmaceuticals
Compare insights from companies similar to Biosortia Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Biosortia Pharmaceuticals
<$5M
11-50
Private
<$5M
2009
CH
Chad HummellBusiness Development Manager, Partnerships Biotech & Pharma
Company Profile Activity
Activity Insights
Biosortia Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Biosortia Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Biosortia Pharmaceuticals.
Biosortia Pharmaceuticals financials insights
Gather financial insights about Biosortia Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$2M
Biosortia Pharmaceuticals Tech Stack
A closer look at the technologies used by Biosortia Pharmaceuticals
See more technologies
Most Recent Scoops
Funding
, a pharmaceutical company, recently secured $675,000 in equity and debt funding.
Funding
Executive Move
Executive Moves, Board of Directors
Funding
Biosortia Pharmaceuticals recently secured $1.53 million in an unknown Series funding round.
Funding
Funding
Biosortia Pharmaceuticals News & Media
Dr. John Ryals added to Biosortia Pharmaceutical Board of Directors
SAN DIEGO, Sept. 11, 2019 /PRNewswire/ -- Biosortia, a leader in the next frontier of drug discovery, accessing the enormous chemical and genomic potential of natural microbiomes, is pleased to announce the addition of leading metabolomics expert, Dr. John Ryals to the Board of Directors....
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Biosortia Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Biosortia Microbiomics specializes in industrial scale microbiome mining, providing a new toolbox for drug discovery by leveraging untapped microbial resources. The company offers a library of novel small molecules derived from natural microbiomes, which are biologically optimized for life science applications. Additionally, Biosortia licenses its... Read More
